Entheon Biomedical (1XU) Financial Statements
Entheon Biomedical Financial Overview
Entheon Biomedical's market cap is currently $486.76K. The company's EPS TTM is $-0.01; its P/E ratio is -4.27; Entheon Biomedical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Feb 26 | Feb 25 | Feb 24 | Feb 23 | Feb 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 250.32K | $ 189.68K | $ 21.67K |
| Gross Profit | $ 0.00 | $ 0.00 | $ 250.32K | $ 189.68K | $ 9.13K |
| Operating Income | $ -334.22K | $ -333.00K | $ -313.00K | $ -3.60M | $ -8.21M |
| EBITDA | $ -334.22K | $ -318.00K | $ 13.99K | $ -3.60M | $ -8.21M |
| Net Income | $ -324.01K | $ -318.00K | $ -300.00K | $ -8.52M | $ -8.89M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 321.83K | $ 136.49K | $ 344.63K | $ 680.17K | $ 2.05M |
| Total Assets | $ 353.78K | $ 185.14K | $ 401.08K | $ 769.22K | $ 9.98M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -321.83K | $ -136.49K | $ -344.63K | $ -680.17K | $ -2.05M |
| Total Liabilities | $ 29.75K | $ 39.81K | $ 85.33K | $ 154.65K | $ 927.71K |
| Stockholders' Equity | $ 324.03K | $ 145.33K | $ 315.75K | $ 614.57K | $ 9.05M |
| Cash Flow | |||||
| Free Cash Flow | $ -314.66K | $ -355.64K | $ -359.93K | $ -1.95M | $ -5.71M |
| Operating Cash Flow | $ -314.66K | $ -355.64K | $ -359.93K | $ -1.95M | $ -5.62M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 24.40K | $ 585.64K | $ -98.87K |
| Financing Cash Flow | $ 500.00K | $ 147.50K | $ 0.00 | $ 0.00 | $ 4.98M |
Currency in CAD